Speaker illustration

Doctor Jonathan Sen

Baker Heart and Diabetes Institute, Melbourne (Australia)

Dr. Jonathan Sen is a cardiologist and clinician-scientist practising in Brisbane, specialising in cardio-oncology after completing a fellowship at the University Health Network (Toronto). He also maintains broad expertise in general cardiology, valvular heart disease, and advanced cardiac imaging. As a current Baker Heart & Diabetes Institute Clinical Affiliate, Dr. Sen’s research aims to improve cardiovascular care by developing better tools for risk prediction and personalised treatment. He believes that insights from rigorous research should directly inform clinical practice. His path hasn't been linear. Undergraduate studies in Canada, medical training across Canberra and Melbourne, a PhD applying machine learning to cardiac risk prediction, and a year embedded with world-leading oncology teams—each step has reinforced a core belief: the best outcomes emerge when research informs practice and when specialists collaborate across traditional boundaries. Learn more at jonathansen.com

Comorbidity is the driver of adverse outcomes in patients with moderate aortic stenosis

Event: ESC Congress 2023

Topic: Aortic Valve Stenosis

Session: The challenging management of moderate aortic stenosis

Thumbnail

Derivation and validation of risk score to predict mortality or heart failure-related hospitalisation based on clinical and echocardiographic factors in moderate or severe aortic stenosis

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: The challenging management of moderate aortic stenosis

Thumbnail

Progression of different echocardiographic parameters of aortic stenosis have different clinical associations

Event: ESC Congress 2023

Topic: Valvular Heart Disease

Session: Valvular heart disease: echocardiography and beyond

Thumbnail

Phenotyping patients with aortic stenosis using cluster analysis to determine mortality and suitability for transcatheter aortic valve replacement

Event: ESC Congress 2022

Topic: Aortic Valve Stenosis

Session: Challenges in transcatheter aortic valve intervention

Thumbnail

CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial

Event: ESC Congress 2020

Topic: Scores

Session: Atrial Fibrillation, Platelet Aggregation and Outcomes

Thumbnail

Effects of patient characteristics and comorbidities on temporal trends of low-flow, low-gradient aortic stenosis phenotypes

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease ePosters

Thumbnail

Clinical outcomes from antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Valvular Heart Disease ePosters

Thumbnail

CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial

Event: ESC Asia with APSC & AFC 2020

Topic: Scores

Session: Abstract Programme

Thumbnail